Allied Health & Imaging · Independent exam preparation
Medical Dosimetry Certification Exam Study Guide
Practise target definition, dose evaluation, calculation checks and treatment safety with 60 focused concepts and original questions aligned to the MDCB outline.
By CertMedbry · Updated 31 October 2026
Learn to distinguish target volumes, interpret dose distributions, compare planning tradeoffs and investigate calculation discrepancies. This guide develops the reasoning used in medical dosimetry through worked decisions, concise explanations and original practice cases. Its 60 concepts selectively cover all seven domains of the January 2027 MDCB examination outline. The official outline remains the full scope for preparation, including topics and practical skills beyond this guide.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination, credential and eligibility pathway does this guide address?
This guide addresses the Medical Dosimetry Certification Exam and the Certified Medical Dosimetrist (CMD) credential awarded by the Medical Dosimetrist Certification Board. It is framed for Route 1 first-time applicants: graduates of a qualifying U.S. JRCERT-accredited dosimetry program who meet the handbook's degree and documentation requirements. The handbook also describes reapplication provisions, including historical Route 2 applicants. Those provisions concern eligibility for the same examination, rather than a separate certification or modality examination.
How many questions are included, and how many are scored?
The January 2027 handbook specifies 155 questions. A small percentage are randomly embedded unscored items used to evaluate new questions. The January 2027 handbook does not specify the exact scored/unscored split.
How long is the examination, and are breaks scheduled?
The allowed examination time is 3 hours 50 minutes, or 230 minutes. The handbook states that there is no scheduled break and describes sign-out, security and return procedures for leaving the testing room. Candidates should follow the current handbook and testing-center instructions.
How is the examination delivered, and is it adaptive?
The examination is delivered in English at computer-based testing centers through Meazure Learning. The handbook identifies locations in the United States and Canada and additional international sites, while specifying knowledge for U.S.-based practice. The handbook does not describe computer-adaptive delivery. Computer-based administration alone does not imply adaptivity.
Which question styles and practical tasks should candidates prepare for?
The handbook includes conventional multiple-choice examples, a drag-and-drop example, and a small number of performance-based multiple-choice and contouring items using ProKnow DS. Practical skills include reviewing anatomy, beam arrangements, isodoses, critical-structure doses and DVHs, and performing specified contours. Approved candidates receive platform practice access. This guide's 20 four-option questions are independent learning drills and do not reproduce the full examination interface or practical assessment.
Which blueprint applies, and what are its domain weights?
The January 21–23, 2027 administration's handbook expressly includes specifications derived from the 2023 Job Task Analysis: Radiation Physics 14%; Localization 8%; Treatment Planning 42%; Dose Calculation Methods 13%; Brachytherapy 5%; Radiation Protection 9%; Quality Assurance & Standard of Care 9%. These percentages concern scored questions. The handbook posting was announced for September 4, 2026. A separate blueprint implementation date is not stated; the administration-specific handbook resolves the older general webpage's pending-implementation wording.
MDCB Applicant Handbook 2027 · MDCB CMD Test Specifications Matrix—2023 Job Task Analysis · MDCB Announce Dates for the 2027 Exam · MDCB Exam Development
How should this selective guide be used alongside official preparation materials?
Use the official matrix as the complete scope, then use these concepts to practise mechanisms and decisions. The 60 concepts, 20 questions and 20 flashcards approximately reflect published domain weights, with rounding for small sets. Add cross-sectional anatomy, contouring and plan-navigation practice through the issuer's resources. Performance on these educational drills does not predict certification results.
MDCB Applicant Handbook 2027 · MDCB CMD Test Specifications Matrix—2023 Job Task Analysis
Independent preparation for the MDCB Medical Dosimetry Certification Exam, which awards the Certified Medical Dosimetrist (CMD) credential. Content follows the examination's U.S.-based practice context; the questions and flashcards are original educational materials.
Outline used: Verified as of 2026-10-13 against the current posted Applicant Handbook 2027, covering the January 21–23, 2027 examination. Its test specifications derive from the 2023 Job Task Analysis. MDCB announced the handbook posting for September 4, 2026; a separate blueprint implementation date is not stated. The workbook label 'Certified Dosimetrist (CMD)' maps to this examination and its awarded credential, Certified Medical Dosimetrist (CMD); the assigned slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Radiation Physics14%
1.How does radioactive decay change source strength?
Radioactive activity decreases exponentially: A(t) = A0 × 2^(−t/T½). Half-life describes the time required for activity to fall by half, regardless of initial activity. For unchanged source geometry, dose rate follows source strength, so delivering the same dose requires more time as a source decays. Distinguish physical half-life from biological elimination and effective half-life; only physical decay applies to a sealed source that remains in place.
Apply it
A sealed source initially has a strength of 80 arbitrary units. After two physical half-lives, its strength is 20 units. With unchanged geometry, a treatment previously requiring five minutes would require twenty minutes for the same dose.
Common pitfall: Subtracting a fixed activity each half-life treats decay as linear. Each interval removes half the activity remaining, rather than half the original activity.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
2.Which photon interactions explain energy-dependent tissue contrast?
Photoelectric absorption transfers photon energy to a bound electron and strongly depends on photon energy and material atomic number. Compton scattering transfers part of the energy to an electron while producing a scattered photon; electron density is especially relevant in megavoltage treatment. Pair production becomes possible above 1.022 MeV. These mechanisms explain why diagnostic bone contrast and megavoltage dose deposition behave differently, although several interactions can coexist within a clinical beam spectrum.
Apply it
A planner compares a diagnostic image with an MV portal image and notices weaker bone contrast in the latter. The change is consistent with reduced photoelectric differentiation and greater relative importance of Compton interactions at treatment energies.
Common pitfall: Selecting an interaction solely because it is energetically possible ignores its relative probability. Pair-production threshold does not establish dominance throughout every megavoltage treatment beam.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
3.How does a linear accelerator produce photon and electron treatments?
A medical linear accelerator accelerates electrons using radiofrequency electromagnetic fields. Photon treatment uses bremsstrahlung generated when accelerated electrons strike a high-atomic-number target. Electron treatment delivers the electron beam using the machine's electron configuration, with scattering or scanning and appropriate collimation. Photon and electron modes therefore have different beam-shaping components and depth-dose behavior. A nominal energy label alone does not identify an interchangeable beam quality, delivery configuration or commissioned clinical dataset.
Apply it
A superficial treatment is changed from photons to electrons. The dosimetrist selects the commissioned electron energy, applicator and insert rather than copying the photon field and MU settings, because both beam formation and dose distribution have changed.
Common pitfall: Assuming equal numerical photon and electron energy labels imply equal penetration overlooks their different interaction mechanisms, spectra and clinical depth-dose characteristics in tissue.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
4.Why do megavoltage photons have a buildup region?
Megavoltage photons release secondary electrons that travel before depositing their energy. Near the surface, electron fluence builds with depth until dose reaches a maximum; beyond that region, attenuation and changing scatter reduce dose. Surface dose and the depth of maximum dose depend on energy, field geometry and electron contamination. The useful decision is whether the intended superficial tissue lies within an underdosed buildup region, requiring an appropriate technique or evaluated bolus arrangement.
Apply it
A target extends to the skin, but the photon plan shows inadequate superficial coverage. The planner evaluates tissue-equivalent bolus with the intended setup and recalculates coverage, recognizing that shifting buildup also changes dose at deeper structures.
Common pitfall: Treating skin sparing as complete protection ignores nonzero surface dose, contamination and setup effects. Adding bolus without recalculation can alter target and organ doses.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
5.How does proton stopping power create a finite treatment range?
Protons lose energy mainly through charged-particle interactions, with increasing energy deposition near the end of their path producing a Bragg peak. Combining energies can cover a target depth interval. Range depends on the integrated stopping properties along the beam path, so tissue changes upstream can shift the distal falloff. This differs from photon attenuation and makes beam-path selection, stopping-power estimation and range uncertainty central to interpreting a proton dose distribution.
Apply it
An aerated cavity lies upstream of a proton target. If the cavity fills with fluid, the beam encounters greater stopping material and may stop more proximally. The planner evaluates this anatomical scenario before relying on nominal distal coverage.
Common pitfall: Calling the Bragg peak a fixed anatomical landmark ignores dependence on beam energy and traversed tissue. A geometrically unchanged target can still receive altered dose.
6.How do distance and projection geometry affect dose and image size?
For a point source in a suitable free-space approximation, intensity varies inversely with squared source-to-point distance. Projection magnification is source-to-image distance divided by source-to-object distance. These relationships answer different questions: one estimates geometric fluence change, while the other relates displayed size to object size. Clinical dose also depends on attenuation, scatter and beam configuration, so a pure inverse-square adjustment is valid only when the stated assumptions isolate distance.
Apply it
A point-source measurement is 12 units at one meter. At two meters, ignoring attenuation and scatter, it becomes three units. Separately, an object halfway between source and detector has a projected size twice its actual size.
Common pitfall: Using detector distance to scale patient dose confuses image magnification with source-to-dose-point geometry. Confirm which distances describe the object, detector and calculation point.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
7.Why must CT numbers be linked to a commissioned density calibration?
A Hounsfield unit expresses CT attenuation relative to water, rather than directly measuring the density quantity required by every dose algorithm. The treatment planning system uses a commissioned relationship to convert CT numbers into electron density, mass density or material information. Scanner settings, reconstruction and artifacts can affect that relationship. For protons, conversion to stopping-power information introduces additional uncertainty. Confirm that the image acquisition protocol and calculation model use the intended calibration.
Apply it
A planning CT is acquired with a different protocol from the validated simulation protocol. Before accepting the calculation, the team checks whether its CT-number relationship is suitable for the commissioned density conversion, especially near bone and implanted metal.
Common pitfall: Assigning the same density meaning to every CT number overlooks scanner and reconstruction dependence. A visually acceptable image does not independently validate its dosimetric calibration.
AAPM Report 85: Tissue Inhomogeneity Corrections for Megavoltage Photon Beams · AAPM Report 202: Physical Uncertainties in the Planning and Delivery of Light Ion Beam Treatments—Full Report
8.Which radiation quantities distinguish activity, absorbed dose and attenuation?
Activity counts nuclear transformations per second and is expressed in becquerels. Absorbed dose is energy deposited per unit mass and is expressed in gray, with 1 Gy equal to 1 joule per kilogram. Equivalent and effective dose use weighting concepts for protection and are expressed in sieverts. Half-value layer describes attenuation thickness for a specified beam and material. The units and physical definition reveal which quantity a calculation actually determines.
Apply it
A worksheet reports a source activity in becquerels and asks for tissue dose in gray. The dosimetrist identifies the missing time, emission, geometry and energy-deposition information instead of treating the two units as directly convertible.
Common pitfall: Equating activity with absorbed dose ignores how emitted energy reaches tissue. Similarly, a shielding half-value layer is not a radioactive source's physical half-life.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
Localization8%
9.What makes a simulation dataset suitable for treatment planning?
A usable simulation dataset must represent the correct patient, orientation, treatment position and clinically intended anatomy. Image extent must support target and organ definition, beam entry paths and external contour construction. Preparation, immobilization and relevant accessories should reproduce treatment conditions. Imported images and structures require checks of identity, coordinates, slice information and associated frame of reference. Missing anatomy can compromise both contouring and dose calculation even when the visible target appears complete.
Apply it
A pelvic scan includes the target but stops before a proposed superior beam entrance region. The planner requests adequate image coverage because an apparently complete target contour cannot compensate for missing patient geometry along a treatment path.
Common pitfall: Accepting a dataset because its patient name and target are visible overlooks orientation, preparation and scan extent. Import success establishes file readability, not clinical suitability.
AAPM TG-275: Strategies for Effective Physics Plan and Chart Review in Radiation Therapy · IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
10.How do immobilization and image guidance address different setup errors?
Immobilization improves reproducibility, while image guidance observes the patient's relationship to the planned reference anatomy. Systematic errors recur in a similar direction across fractions; random errors vary between fractions. A consistent reference-coordinate mistake may therefore displace an entire course, whereas variable organ filling produces changing anatomy. Registration and correction must use a clinically appropriate target or surrogate. External alignment alone cannot demonstrate internal agreement when organs move relative to skin or bone.
Apply it
A pelvic patient's skin marks align daily, but volumetric images show variable prostate position relative to bone. The team uses the specified internal localization method and preparation strategy rather than assuming improved external immobilization alone resolves the discrepancy.
Common pitfall: Treating every shift as random can conceal a repeated reference error. Conversely, one correction does not eliminate subsequent internal motion or intrafraction change.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students · AAPM TG-132: Use of Image Registration and Fusion Algorithms and Techniques in Radiotherapy
11.How should respiratory motion influence simulation and treatment strategy?
Respiratory-correlated imaging samples anatomy across breathing states, helping characterize target motion and its relationship to nearby organs. Irregular breathing can create sorting artifacts and incomplete motion representation. An internal target approach encompasses an assessed motion envelope, while gating, breath hold and tracking attempt to restrict or follow motion. Selection depends on reproducibility, residual motion and the relationship between the monitored signal and internal anatomy. Motion assessment must match the intended treatment technique.
Apply it
A lung simulation shows inconsistent diaphragm positions between reconstructed phases and visible discontinuities. Before defining a motion envelope, the team investigates breathing and sorting quality, because an artifact-expanded contour could misrepresent both target location and excursion.
Common pitfall: Assuming a respiratory surrogate always tracks the tumor ignores changing internal-external correlation. A gated treatment still requires assessment of residual motion and baseline shifts.
AAPM TG-324 Report 91.b: The Management of Respiratory Motion in Radiation Oncology
12.When is rigid image registration an appropriate alignment model?
Rigid registration uses translations and rotations while preserving distances and shape within the moving image. It is useful when the anatomy of interest behaves approximately as a rigid body, such as selected bony structures. The registration region should match the clinical purpose, and results require inspection in all planes near relevant targets and organs. A globally satisfactory alignment can remain locally inaccurate when soft tissue changes independently of the chosen registration anatomy.
Apply it
A head-and-neck MRI aligns well to the skull base but differs near the lower neck because positioning changed. The planner inspects the local anatomy before transferring contours rather than accepting a single global registration score as sufficient.
Common pitfall: Expecting a rigid transform to correct deformation confuses alignment with shape change. Perfect agreement in one region can coexist with clinically significant disagreement elsewhere.
AAPM TG-132: Use of Image Registration and Fusion Algorithms and Techniques in Radiotherapy
13.How should a deformable registration be validated for its intended use?
Deformable registration estimates spatially varying correspondence between images. Its usefulness depends on image quality, anatomical similarity and the clinical task, such as contour propagation or dose mapping. Validation combines local anatomical inspection, relevant landmarks or contours and assessment of implausible deformation. Agreement should be examined where a decision depends on it. Anatomy that appears, disappears or changes topology may lack a meaningful one-to-one correspondence, limiting interpretation even when the algorithm produces an output.
Apply it
An automated deformation maps a planning bladder onto a much fuller daily bladder. The reviewer inspects the wall and neighboring target locally before using propagated contours, recognizing that a smooth-looking transformation can still misplace a clinically important boundary.
Common pitfall: Using one overlap statistic as universal approval ignores local errors and task dependence. Validation adequate for contour editing may be inadequate for quantitative dose accumulation.
AAPM TG-132: Use of Image Registration and Fusion Algorithms and Techniques in Radiotherapy
Treatment Planning42%
14.What distinguishes gross tumor volume from clinical target volume?
Gross tumor volume represents demonstrable macroscopic disease. Clinical target volume includes gross disease when present and additional tissue considered at risk for microscopic disease. Its definition depends on disease biology, anatomy and routes of spread rather than setup uncertainty alone. A postoperative clinical target may exist without a remaining gross tumor. The discriminating question is whether a boundary represents known or suspected disease, rather than motion or uncertainty in positioning during treatment.
Apply it
After resection, imaging shows no residual mass, but the radiation oncologist identifies a surgical bed at risk for microscopic disease. The planner recognizes a valid clinical target volume without inventing a gross tumor solely to create nested structures.
Common pitfall: Defining the clinical target as a uniform setup expansion mixes disease extent with geometric uncertainty. Anatomical barriers and clinical judgment can make its shape nonuniform.
15.How do internal and planning target volumes address uncertainty?
An internal target volume accounts for assessed variations in clinical target position, size or shape, such as respiratory movement. A planning target volume is a geometrical planning construct that accommodates relevant positioning and internal uncertainties so the clinical target can receive the intended dose. The exact construction depends on the adopted margin framework and motion-management method. Distinguish tissue at risk from the geometrical allowance needed to cover it reliably during actual treatment.
Apply it
A moving lung target is planned using an assessed respiratory envelope and an additional setup allowance. The planner documents which uncertainty each expansion addresses, preventing the same respiratory excursion from being included twice in successive margin steps.
Common pitfall: Treating the planning target as additional tumor tissue obscures its geometric purpose. Copying a margin from another technique can also misrepresent residual uncertainty.
IAEA-TECDOC-1560: Dose Reporting in Ion Beam Therapy · AAPM TG-324 Report 91.b: The Management of Respiratory Motion in Radiation Oncology
16.Why use a planning organ-at-risk volume?
A planning organ-at-risk volume adds a geometrical allowance around an organ to account for relevant positional or delineation uncertainty. It helps the planner manage the possibility that the actual organ lies closer to a high-dose region than the nominal contour suggests. The underlying organ remains the anatomical structure used for its specified reporting metrics. The planning allowance and any associated objective must follow the chosen clinical approach rather than being treated as a universal tolerance.
Apply it
A steep dose gradient lies beside the spinal cord. The planner evaluates the cord and its approved planning allowance separately, checking how uncertainty affects the tradeoff rather than substituting the expanded structure's statistics for every cord reporting requirement.
Common pitfall: Assuming an expanded organ has the same meaning as the anatomical organ can misapply constraints. Expansion size and acceptance criteria require an explicit clinical basis.
17.How should cumulative DVH metrics be interpreted?
A cumulative dose-volume histogram shows the volume receiving at least each dose. Vx reports volume at or above a specified dose, while Dx reports the dose received by a specified volume or percentage. Units matter: an absolute cubic-centimeter metric differs from a percentage metric. DVHs efficiently compare coverage and organ exposure, but they discard spatial location. A valid assessment therefore pairs numerical metrics with anatomy, contours and the three-dimensional dose distribution.
Apply it
A target has V60 Gy = 95%. This means 95% receives at least 60 Gy, rather than receiving exactly that dose. The planner then inspects where the remaining 5% lies and whether it involves clinically important target tissue.
Common pitfall: Confusing D95 with V95 changes both the input and output quantity. Also, identical DVHs can arise from spatially different cold spots or organ hotspots.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
18.Why must isodose review accompany numerical plan comparison?
Isodose displays preserve the spatial relationship between dose, target anatomy and organs. They reveal whether a hotspot is inside intended target tissue, whether a cold region follows an anatomical boundary and whether dose extends into an unexpected region. Review in axial, sagittal and coronal planes helps identify superior-inferior problems that a single slice can miss. Numerical acceptance and spatial acceptability answer related but different questions, so neither replaces the other in plan evaluation.
Apply it
Two plans have similar target coverage and maximum dose. One places its hotspot centrally within the target; the other places it beside a sensitive organ outside the target. Spatial review distinguishes the clinically relevant tradeoff hidden by the summary table.
Common pitfall: Approving a plan from a single favorable slice or DVH can miss localized errors. A smooth-looking color wash also depends on displayed levels and interpolation.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students · AAPM TG-275: Strategies for Effective Physics Plan and Chart Review in Radiation Therapy
19.How does organ architecture influence dose-metric selection?
A serial-organ model emphasizes the consequences of damaging a critical segment, making near-maximum or small-volume dose especially relevant. A parallel-organ model emphasizes the remaining functional volume, making mean dose and volume-based metrics useful. These are simplified biological models, not automatic rules that replace a specific protocol. The relevant endpoint, contour definition, fractionation and organ substructure determine which metrics should govern a particular planning decision and how hotspots should be interpreted.
Apply it
A plan reduces mean spinal cord dose but increases a small high-dose region. The planner does not assume improvement from the mean alone, because a critical segment can matter more than the average exposure across the entire contoured cord.
Common pitfall: Calling an organ serial or parallel does not establish a universal numerical tolerance. Different clinical endpoints and substructures can require different metrics within one organ.
AAPM Report 166: The Use and QA of Biologically Related Models for Treatment Planning
20.How does fraction size change biologically effective dose?
Under the basic linear-quadratic model with adequate repair and no added time correction, BED = nd[1 + d/(α/β)], where n is fraction count and d is dose per fraction. The α/β ratio characterizes fraction-size sensitivity; a lower value produces a larger BED increase when fraction size rises. Compare schedules using the same tissue endpoint and assumptions. BED is model-dependent and does not by itself establish clinical equivalence or safety.
Apply it
For a hypothetical α/β of 3 Gy, 30 Gy in ten 3-Gy fractions gives BED3 = 30 × (1 + 3/3) = 60 Gy3. The same physical total delivered in smaller fractions would have a lower calculated BED3.
Common pitfall: Comparing physical totals alone ignores fraction-size sensitivity. Applying the basic equation without considering repair, overall time or model limitations can overstate its clinical precision.
21.How does EQD2 support fractionation comparisons?
Equivalent dose in 2-Gy fractions converts a calculated biological effect into the physical dose that would produce that effect using 2-Gy fractions under the same model. EQD2 = BED/[1 + 2/(α/β)]. Specify the tissue α/β value and relevant repair or time assumptions. This conversion helps compare differing fraction sizes, but it does not supply spatial correspondence, tissue recovery or validated tolerance information for a previously irradiated organ.
Apply it
A hypothetical course has BED3 of 60 Gy3. Dividing by 1 + 2/3 gives an EQD2 of 36 Gy for that α/β assumption. The planner records the tissue model before comparing it with another schedule.
Common pitfall: Adding EQD2 values calculated with different α/β assumptions mixes biological endpoints. A converted number also cannot reveal whether both courses irradiated the same tissue.
22.Why are LET, RBE and oxygen effects different concepts?
Linear energy transfer describes energy deposited per unit track length. Relative biological effectiveness compares doses of a reference and test radiation producing the same specified biological endpoint. Oxygen can enhance radiation damage, particularly for low-LET radiation, through fixation of damage. These quantities are related but not interchangeable. RBE depends on radiation quality, endpoint, dose and biological conditions; it should not be treated as a universal property determined solely by a particle's name or nominal energy.
Apply it
A comparison describes two beams with different track structures. The planner distinguishes their physical dose distributions from any biological weighting and asks which endpoint and model support the stated RBE before interpreting a biologically weighted dose.
Common pitfall: Equating higher LET with a fixed numerical RBE ignores endpoint and dose dependence. Physical dose and biologically weighted dose must retain their stated meanings.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students · IAEA-TECDOC-1560: Dose Reporting in Ion Beam Therapy
23.How do breast lymphatic pathways and axillary landmarks inform target review?
Breast cancer can spread microscopically through lymphatic channels to regional nodes, including the ipsilateral axillary and internal mammary chains. In the axilla, pectoralis minor provides an anatomical reference: level I nodes lie lateral to its lateral border, level II nodes lie behind it, and level III nodes lie medial to its medial border. Internal mammary nodes follow the internal thoracic vessels beside the sternum. These landmarks identify regions; they do not establish which regions require treatment. Regional spread is described in the [NCI Breast Cancer Treatment PDQ](https://www.cancer.gov/types/breast/hp/breast-treatment-pdq).
Apply it
On axial images, locate pectoralis minor between the anterior chest wall and axillary vessels, then follow it in coronal and sagittal views to distinguish lateral, posterior and medial nodal regions. If a structure labeled level II lies entirely lateral to the muscle, flag the anatomical mismatch. The radiation oncologist determines elective nodal inclusion from disease extent, surgery and clinical risk.
Common pitfall: Lymphatic drainage explains a route of microscopic spread, but it does not prove involvement or require treatment of every regional chain. Nodal spread can also bypass an expected sequential level.
MDCB CMD Test Specifications Matrix—2023 Job Task Analysis · AAPM TG-275: Strategies for Effective Physics Plan and Chart Review in Radiation Therapy
24.How do breast tangents and breath hold change organ exposure?
Tangential breast fields use beam geometry to encompass intended breast tissue while limiting passage through deeper thoracic structures. Deep-inspiration breath hold changes thoracic geometry and may increase separation between the heart and the treated region in suitable patients. Benefit must be demonstrated on the patient's actual anatomy and maintained through a reproducible breath-hold workflow. Field borders, flash, target coverage and lung exposure remain relevant; one improved organ metric does not establish overall plan acceptability.
Apply it
A left-breast breath-hold scan shows the heart farther from the tangential high-dose region than on free breathing. The planner compares coverage and organ doses, while the team confirms that the patient can reproduce the planned breath-hold position.
Common pitfall: Assuming every breath hold produces the same cardiac benefit ignores individual geometry and reproducibility. Excessively tightening fields to spare an organ can compromise target coverage.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students · AAPM TG-324 Report 91.b: The Management of Respiratory Motion in Radiation Oncology
25.Why does pelvic preparation affect plan reliability?
Bladder and rectal filling can change target position, organ shape and the amount of normal tissue near a high-dose region. A preparation strategy aims to produce anatomy that is clinically suitable and reproducible, rather than maximizing one organ's volume without regard to treatment feasibility. The simulation state should represent achievable treatment conditions. Daily imaging can reveal deviations, but a translational correction cannot always resolve deformation or altered relationships among pelvic structures.
Apply it
A pelvic plan is optimized on an unusually distended bladder that the patient cannot reproduce. Daily images then show different bowel and target relationships. The team reassesses preparation and planning suitability instead of treating every difference as a simple couch shift.
Common pitfall: Assuming a larger bladder is always better ignores discomfort and reproducibility. Matching pelvic bones does not prove that target and soft-tissue organ geometry also match.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students · AAPM TG-132: Use of Image Registration and Fusion Algorithms and Techniques in Radiotherapy
26.Which pelvic landmarks distinguish the prostate, bladder, rectum and seminal vesicles?
In the intact male pelvis, the prostate lies inferior to the bladder, posterior to the pubic symphysis and anterior to the rectum. Its base meets the bladder neck superiorly; its apex points inferiorly toward the external urethral sphincter. The paired seminal vesicles lie posterior to the bladder and superior to the prostate base, anterior to the rectum. Axial images establish anterior-posterior relationships; sagittal images distinguish bladder neck, base and apex; coronal images help follow paired seminal vesicles. The [NCI Prostate Cancer Treatment PDQ](https://www.cancer.gov/types/prostate/hp/prostate-treatment-pdq) provides the clinical anatomical context.
Apply it
A prostate contour extends posteriorly into the rectal lumen. Identify the rectal wall and lumen on axial images, then inspect the sagittal prostate-rectum interface to locate the inconsistency. At the superior boundary, distinguish the bladder neck from the posteriorly situated seminal vesicles. Use suitable MRI when CT does not adequately resolve an interface.
Common pitfall: Anatomical identification does not authorize changing the physician's target selection. A prostate-only target and a target deliberately including seminal vesicles have different clinical definitions even though the underlying landmarks are unchanged.
MDCB CMD Test Specifications Matrix—2023 Job Task Analysis · AAPM TG-275: Strategies for Effective Physics Plan and Chart Review in Radiation Therapy · AAPM TG-132: Use of Image Registration and Fusion Algorithms and Techniques in Radiotherapy
27.How should beam geometry guide forward planning?
Forward planning begins with clinically selected beam directions, shapes, energies and weights, followed by calculation and adjustment. Beam's-eye views show projected targets and organs, while three-dimensional dose reveals the combined result. Geometry determines which tissues every beam must traverse and where dose can overlap. Field-in-field segments can improve homogeneity by selectively reducing high-dose regions. Choose modifications based on the cause of a dose problem rather than repeatedly adjusting weights without examining anatomy.
Apply it
A tangential plan has a localized high-dose region in thinner tissue. The planner considers a field-in-field segment that reduces fluence through that region while retaining coverage elsewhere, then recalculates to verify the intended improvement.
Common pitfall: Increasing every beam weight to correct one cold region also raises dose elsewhere. A projection that avoids an organ does not independently establish acceptable composite dose.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
28.How do inverse-planning objectives differ from final acceptance criteria?
Inverse planning adjusts fluence or machine parameters to reduce an objective function built from target and organ goals. Weights and penalties influence the optimizer's tradeoffs; they are not guarantees that the final calculated plan meets clinical criteria. Conflicting objectives, delivery constraints and dose-calculation updates can alter the result. Evaluate the final deliverable dose against the prescription and applicable protocol, including spatial distribution, rather than interpreting a favorable optimization score as clinical approval.
Apply it
An optimizer reports a lower total cost after a weight change, but final calculation shows worse target coverage. The planner examines which penalty improved and restores the clinically required balance instead of accepting the lower score as sufficient evidence.
Common pitfall: Treating objective weights as clinical priorities can hide unintended tradeoffs. Optimization metrics may use surrogate structures, sampling or dose approximations that differ from final reporting.
AAPM Report 166: The Use and QA of Biologically Related Models for Treatment Planning · IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
29.When are biological optimization models useful?
Biological objectives, including equivalent uniform dose and modeled complication or control probabilities, summarize heterogeneous dose using assumptions about tissue response. They can support plan comparison and optimization, but their parameters and validity depend on the endpoint and population. A model may assign similar scores to distributions with clinically different hotspots. Pair model-based objectives with physical dose limits, spatial inspection and appropriate validation so model uncertainty does not become an unrecognized planning decision.
Apply it
Two plans have similar modeled organ complication probabilities, but one contains a concentrated hotspot beside the target. The planner reviews the hotspot and physical dose metrics because a comparable model output does not establish equivalence for that patient's anatomy.
Common pitfall: Interpreting a modeled probability as an individualized clinical forecast overstates parameter certainty. A biological objective should not erase explicit physical constraints or hotspot review.
AAPM Report 166: The Use and QA of Biologically Related Models for Treatment Planning
30.How does multicriteria planning expose treatment tradeoffs?
In Pareto-based multicriteria optimization, a feasible plan satisfies the stated constraints. A feasible plan is nondominated, or Pareto optimal, when no objective can improve without worsening another. Navigation explores tradeoffs by combining precomputed plans to approximate a Pareto surface. Craft and Richter's 2012 study distinguishes idealized fluence-map navigation from deliverable navigation: converting fluence maps into machine segments can change the dose distribution. A navigated fluence solution therefore requires segmentation, final calculation and renewed acceptance checks. Their alternative explores combinations of already segmented plans while controlling segment burden.
Apply it
Reducing one parotid's mean dose consistently increases dose to another avoidance structure. The planner presents feasible alternatives with their target metrics intact so the physician can judge the tradeoff, then verifies that the selected balance survives conversion to the final deliverable plan.
Common pitfall: Pareto optimality establishes efficiency only for the specified objectives and constraints. It neither validates omitted clinical requirements nor guarantees that subsequent segmentation preserves the navigated dose.
31.Why create optimization rings and avoidance structures?
Auxiliary planning structures shape how an optimizer distributes dose outside or within a target. Rings can encourage controlled dose falloff, while avoidance structures can distinguish an organ region from an overlap with the target. These structures are optimization tools rather than newly defined anatomy. Their construction should preserve original clinical contours and reporting metrics. Overly restrictive objectives near target boundaries can create coverage loss or excessive modulation, so the resulting distribution requires anatomical review.
Apply it
A planner adds a ring outside a stereotactic target to reduce dose spill. After optimization, target-edge coverage worsens. The ring's distance and objective are revised, and the clinical target and organ metrics are checked on their original structures.
Common pitfall: Reporting only a cropped organ can hide dose in the excluded overlap. Auxiliary structures should not silently replace the anatomical structures required by a protocol.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students · AAPM Report 166: The Use and QA of Biologically Related Models for Treatment Planning
32.How is a named fractionation-specific organ constraint applied?
Use the original 2010 [AAPM TG-101 report, Table III](https://doi.org/10.1118/1.3438081) for this worked example. For the spinal cord and medulla in three-fraction SBRT, its recommended upper-dose criteria are D0.35 cm3 < 18 Gy, D1.2 cm3 < 12.3 Gy and maximum point dose < 21.9 Gy. Apply these to the anatomical neural structure, not an interchangeable spinal-canal contour or expanded PRV. These are TG-101 recommendations; a clinical trial or institutional protocol may prescribe different criteria. The example assumes an initial course without prior cord irradiation.
Apply it
For a hypothetical lung SBRT course delivered in three fractions, the correctly contoured cord has D0.35 cm3 = 17.4 Gy, D1.2 cm3 = 11.8 Gy and maximum point dose = 21.2 Gy. All three values satisfy the stated TG-101 criteria. If D0.35 cm3 rises to 18.4 Gy, that criterion fails even if mean dose falls and the other two criteria remain satisfied.
Common pitfall: TG-101's five-fraction D0.35 cm3 criterion of < 23 Gy cannot replace its three-fraction < 18 Gy criterion. D0.35% is also a different metric, and a dose measured on the spinal canal or a PRV cannot silently substitute for the specified neural structure. Passing these cord criteria alone does not establish overall plan acceptability.
MDCB Applicant Handbook 2027 · AAPM Report 166: The Use and QA of Biologically Related Models for Treatment Planning
33.Why do stereotactic plans demand careful gradient and geometry review?
Stereotactic techniques combine precise localization with highly conformal dose, often delivered in relatively few fractions. A steep gradient can spare nearby tissue but also makes small geometric errors consequential. Evaluate target coverage, high-dose conformity, intermediate-dose spread and organ dose using the applicable clinical criteria. Small fields and fine anatomical features also challenge calculation and measurement. A visually compact high-dose region is insufficient if uncertainty, residual motion or calculation resolution undermines reliable delivery.
Apply it
A small target lies close to a sensitive structure. Although nominal conformity is favorable, a plausible displacement moves the high-dose edge into that structure. The team reviews localization, uncertainty and planning tradeoffs before accepting the sharp gradient.
Common pitfall: Pursuing the steepest possible gradient can reduce robustness. Small nominal organ doses are meaningful only when contouring, calculation and localization support that spatial separation.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students · AAPM Medical Physics Practice Guideline 5.b: Commissioning and QA of Treatment Planning Dose Calculations
34.How should electron energy and field geometry be selected?
Electron planning exploits a finite useful range and relatively rapid distal dose reduction, making it suitable for selected superficial targets. Energy must cover the required depth while limiting dose beyond it. Applicator, insert size, surface curvature, obliquity and tissue heterogeneity can change output and depth-dose behavior. Small fields may lose lateral scatter equilibrium. Use commissioned beam data and the actual treatment geometry rather than relying on a depth rule of thumb alone.
Apply it
A superficial lesion is treated through a narrow electron insert on a curved surface. The planner checks coverage and output for that insert and geometry, because standard broad-field depth-dose data may not adequately describe the intended field.
Common pitfall: Choosing energy from target depth alone overlooks field-size and obliquity effects. A higher energy can improve distal coverage while unnecessarily increasing dose to deeper tissue.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students · AAPM TG-71: Monitor Unit Calculations for External Photon and Electron Beams
35.How does robust proton evaluation differ from nominal coverage review?
Robust evaluation examines dose under specified uncertainty scenarios, commonly including setup displacement and stopping-power or range variation. A nominal plan can look acceptable while a plausible scenario produces undercoverage or organ overdose. Proton range effects follow beam paths and do not behave like a simple isotropic geometric expansion. Evaluate clinically relevant target and organ metrics across the chosen scenarios, considering anatomical change and documenting which uncertainties the scenario set actually represents.
Apply it
A proton plan meets nominal coverage, but an increased-range scenario places distal dose in a nearby organ. The planner revisits beam orientation or optimization and evaluates the revised scenario distributions instead of relying on the nominal planning-target DVH.
Common pitfall: Assuming a larger geometric margin solves every proton uncertainty ignores depth-dependent range behavior. A favorable worst-case metric also depends on the scenarios that were included.
36.When should anatomical change prompt adaptive assessment?
Adaptive assessment is warranted when observed changes may invalidate the original relationship among anatomy, beam paths and planned dose. Examples include substantial contour change, altered organ filling, target regression or changing air cavities. A setup correction can restore alignment without restoring the original internal geometry. Compare current anatomy with the planning assumptions and assess dosimetric consequences using an appropriate validated workflow. Replanning decisions should follow clinical significance and established responsibilities rather than appearance alone.
Apply it
A head-and-neck patient loses external contour volume, and daily imaging shows changed tissue thickness along several beam paths. The team assesses dose on suitable updated anatomy before deciding whether a revised plan is required for the remaining course.
Common pitfall: Replanning every visible change may add work without benefit, while ignoring all changes after a successful alignment can miss meaningful coverage or organ-dose alterations.
AAPM TG-275: Strategies for Effective Physics Plan and Chart Review in Radiation Therapy · AAPM Report 202: Physical Uncertainties in the Planning and Delivery of Light Ion Beam Treatments—Full Report
37.How do implanted cardiac devices influence planning decisions?
Cardiac implantable electronic device management considers device type, patient dependence, estimated device dose and whether treatment can produce secondary neutrons. Under TG-203, neutron-producing treatment places the patient in the high-risk category even when estimated generator dose is low. Planning should identify the generator, avoid direct irradiation when feasible and evaluate beam-energy choices with the clinical team. Patient dependence affects the consequences of malfunction and management needs. Target prescription or field-edge distance alone cannot establish the device-risk category.
Apply it
A pacemaker lies outside the treatment field, and its estimated dose is low, but the proposed beam can generate secondary neutrons. The planner identifies the TG-203 high-risk classification and coordinates technique selection and the corresponding management pathway with physics and the treating team.
Common pitfall: A low generator dose or lack of pacing dependence does not downgrade neutron-producing treatment to low risk. Device presence also does not automatically prohibit clinically necessary radiotherapy.
38.How should automated planning and electronic transfers be checked?
Automation can reproduce contouring, optimization and transfer tasks efficiently, but a template or script can also reproduce an error consistently. Validate intended inputs, units, structure identities and outputs, then review patient-specific anatomy and dose. Electronic transfer requires confirmation of plan identity, version, coordinates, prescription and machine parameters in the receiving system. Preserve traceable approved records and recoverable data. Successful execution or transfer demonstrates technical completion, not clinical correctness or approval of the resulting plan.
Apply it
A script creates avoidance structures and exports a plan. Review shows it selected an outdated target with a similar name. The team corrects the input-selection rule, regenerates the outputs and verifies the transferred approved version before treatment.
Common pitfall: Assuming deterministic automation is automatically accurate confuses repeatability with correctness. A checksum or successful import cannot establish that the clinically intended plan was selected.
AAPM TG-275: Strategies for Effective Physics Plan and Chart Review in Radiation Therapy · AAPM Medical Physics Practice Guideline 5.b: Commissioning and QA of Treatment Planning Dose Calculations
Dose Calculation Methods13%
39.Which photon dose algorithms are acceptable for heterogeneous anatomy?
AAPM MPPG 5.b section 6 requires advanced algorithms for heterogeneous photon dose calculations, including thoracic treatments. It identifies pencil-beam and correction-based algorithms as unacceptable for this purpose. Suitable advanced methods must account for relevant heterogeneity and secondary-electron transport and must be commissioned for the intended clinical use. Commissioning remains necessary, but it does not make an otherwise unacceptable algorithm class suitable for heterogeneous thoracic calculations. Historical pencil-beam comparisons can illustrate missing transport physics without establishing clinical acceptability.
Apply it
A small photon field crosses low-density lung before reaching a target. Select an appropriately commissioned advanced algorithm and validated settings. An educational comparison with radiological-depth scaling may show how lateral electron disequilibrium changes interface dose, but that simpler calculation is not an acceptable clinical substitute.
Common pitfall: Heterogeneity changes both photon transport and nonlocal energy deposition by secondary electrons. Matching radiological depth or obtaining agreement in homogeneous water does not establish accuracy in lung.
AAPM Medical Physics Practice Guideline 5.b: Commissioning and QA of Treatment Planning Dose Calculations · AAPM Report 85: Tissue Inhomogeneity Corrections for Megavoltage Photon Beams
40.How should a monitor-unit calculation use beam factors?
A monitor-unit calculation divides the required point dose by the dose delivered per MU under the actual treatment conditions. The denominator must consistently include the applicable output, depth, geometry and modifier relationships for the chosen formalism. Factors must match their definitions and reference conditions; some data are already combined in measured quantities. An independent check should identify assumptions and reconcile differences with the treatment planning calculation rather than merely reproduce its final number.
Apply it
A hypothetical field must deliver 180 cGy at a point. Its fully adjusted dose per MU is 0.75 cGy/MU, giving 240 MU. The planner confirms that modifier and distance effects are already included before applying any additional factors.
Common pitfall: Multiplying by a transmission factor after using an already corrected dose per MU double-counts attenuation. Mixing SSD and isocentric conventions can similarly produce a systematic error.
AAPM TG-71: Monitor Unit Calculations for External Photon and Electron Beams
41.How do bolus, wedges and multileaf collimators alter calculated dose?
Beam modifiers change more than the visible field outline. Bolus adds buildup material and alters effective tissue depth; wedges change fluence across a field; multileaf collimators shape fluence while introducing transmission, leakage and leaf-end effects. The calculation must represent the actual accessory and geometry using commissioned data. Distinguish an intentional physical change from an optimization objective: an objective requests a distribution, while the modifier changes how radiation reaches the patient.
Apply it
A photon plan is recalculated after removing bolus from several fractions. The planner assesses both superficial coverage and deeper dose, because the change affects buildup and attenuation rather than simply toggling a cosmetic planning structure.
Common pitfall: Using a single transmission factor to describe every modifier effect can miss spatial and spectral changes. Unmodeled air gaps beneath bolus may also affect intended coverage.
AAPM TG-71: Monitor Unit Calculations for External Photon and Electron Beams · IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
42.When is a density override justified?
A density override replaces image-derived material information when there is a justified reason that the original values do not represent the intended calculation anatomy. Examples include identified artifacts or a deliberately modeled scenario. The assigned material or density must have a defensible basis, and its extent should follow the actual uncertainty. Preserve real heterogeneity unless the clinical calculation purpose requires otherwise. Compare relevant outcomes and document assumptions because overrides can materially alter attenuation, scatter and particle range.
Apply it
Metal streaks extend through tissue near a prosthesis. The team distinguishes the implant from corrupted surrounding tissue and assigns justified values only where needed, then evaluates sensitivity instead of converting the entire region to water without review.
Common pitfall: Overriding every unusual CT number can erase genuine anatomy. A convenient water assignment may improve appearance while worsening the physical accuracy of the dose calculation.
AAPM Report 85: Tissue Inhomogeneity Corrections for Megavoltage Photon Beams · AAPM Report 202: Physical Uncertainties in the Planning and Delivery of Light Ion Beam Treatments—Full Report
43.How does dose-grid resolution affect plan interpretation?
A dose grid samples a continuous distribution at discrete locations. Coarse sampling can blur steep gradients, miss small hotspots or alter metrics for small structures. Finer resolution improves spatial representation but does not repair an inaccurate beam model or incorrect anatomy. Interpolation and structure sampling also influence reported values. Use clinically validated settings appropriate to field size and geometry, and investigate changes that affect decisions rather than assuming every extra displayed decimal is physically meaningful.
Apply it
A tiny organ sits next to a stereotactic target, and its reported near-maximum dose changes with grid size. The planner evaluates convergence using commissioned settings and inspects the gradient before interpreting the difference as a true planning improvement.
Common pitfall: Selecting the finest available grid does not guarantee accuracy. Conversely, a stable target mean dose cannot prove that a coarse grid adequately resolves a nearby small organ.
44.Why must field junctions be evaluated at clinically relevant depths?
Diverging fields can overlap or separate beneath the surface even when their skin borders appear matched. Junction dose depends on beam geometry, depth, field size and setup reproducibility. A geometrical surface gap may align field edges at one selected depth but cannot ensure uniform dose everywhere. Evaluate the composite distribution and plausible positioning changes. Junction feathering can redistribute a systematic hotspot or cold region, but it requires an intentional, verified treatment scheme.
Apply it
Two adjacent fields appear perfectly abutted on the skin. Composite calculation reveals overlap at depth from divergence. The planner revises the matching geometry and checks the resulting dose across the junction instead of approving the surface appearance alone.
Common pitfall: A surface match is not a volumetric dose match. A geometrical gap calculation also does not account for every penumbra, scatter or delivery uncertainty.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
45.What limits confidence in deformable dose accumulation?
Dose accumulation across changing anatomy requires an estimated correspondence between tissue locations, not merely image alignment. Registration errors, missing tissue and changing organ contents can make mapped dose uncertain or physically ambiguous. A deformation acceptable for contour propagation may still be inadequate where dose gradients are steep. Evaluate local correspondence, dose-mapping assumptions and sensitivity before interpreting accumulated metrics. The summed display should retain its uncertainty rather than implying that each mapped voxel represents a verified tissue history.
Apply it
A shrinking tumor and changing bowel configuration produce an attractive accumulated-dose display. The reviewer checks correspondence near the limiting organ and reports uncertainty, recognizing that dose mapped through disappearing tissue or changing contents may lack a reliable anatomical interpretation.
Common pitfall: Adding warped dose grids does not prove tissue-level accuracy. A smooth deformation and plausible total dose can conceal incorrect mapping across a steep gradient.
AAPM TG-132: Use of Image Registration and Fusion Algorithms and Techniques in Radiotherapy
46.How should prior irradiation be incorporated into a new calculation?
Retreatment assessment begins with reliable prior prescription, delivered fractions, dose distributions and anatomical context. Physical-dose addition is insufficient when fraction sizes differ; biological conversion requires explicit tissue assumptions. Spatial correspondence, uncertain historical data and possible tissue recovery add separate limitations. Identify the organ region receiving overlapping exposure and present cumulative estimates with their assumptions. A prior course's target prescription cannot substitute for the actual dose received by the organ now limiting the new plan.
Apply it
A previous treatment prescribed 50 Gy, but the current limiting organ received a nonuniform lower dose. The planner obtains the prior distribution and delivered-course information, then evaluates relevant overlap and fractionation rather than subtracting 50 Gy from an assumed allowance.
Common pitfall: Assuming complete recovery after a chosen interval invents biological certainty. Adding separate-course organ maxima can also overestimate or underestimate risk when their locations differ.
21 Years of Biologically Effective Dose · AAPM TG-132: Use of Image Registration and Fusion Algorithms and Techniques in Radiotherapy
Brachytherapy5%
47.How does brachytherapy geometry determine local dose?
Brachytherapy places radioactive sources near or within the treatment region, producing steep dose gradients. A point-source inverse-square approximation helps explain sensitivity to distance, but clinical source calculations also account for source geometry, radial dose behavior and anisotropy. Source strength must use the appropriate specified quantity and calibration. Small reconstruction errors can therefore change nearby target or organ doses substantially, making source location and applicator geometry essential inputs rather than incidental image details.
Apply it
A reconstructed source position shifts toward an adjacent organ by a few millimeters. The planner recalculates the organ's small-volume dose rather than assuming the change is negligible because the overall implant and prescription remain unchanged.
Common pitfall: Applying inverse square alone near an extended source ignores geometry and anisotropy. Using activity as though it were a complete clinical source-strength specification can also mislead.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
48.How do HDR dwell positions and source decay affect treatment time?
An HDR afterloader moves a source through specified channels and dwell positions, with dwell times determining the contribution from each location. The plan depends on correct applicator reconstruction, channel identity, source-path geometry and current source strength. With unchanged geometry and desired dose, total time scales inversely with source strength as the source decays. Global time scaling cannot repair an incorrect dwell position or channel assignment because those errors change where dose is deposited.
Apply it
The same validated geometry is recalculated with source strength reduced to 80% of its former value. Equivalent dose requires dwell times multiplied by 1/0.8, or 1.25, provided the source model and all other treatment conditions remain unchanged.
Common pitfall: Increasing total time cannot correct a misplaced dwell pattern. A plausible treatment duration also does not establish that channels, reconstruction or current source calibration are correct.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
49.What survey confirms source return after NRC-regulated remote afterloading?
For NRC-regulated remote afterloading, [10 CFR 35.604](https://www.ecfr.gov/current/title-10/chapter-I/part-35/subpart-H/section-35.604) requires surveying both the patient and the remote afterloader unit with a portable radiation detection survey instrument before releasing the patient from licensee control. The survey confirms that the source has been removed from the patient and returned to a safe, shielded position. Survey records must be retained under 10 CFR 35.2404. This is a U.S. NRC requirement; Agreement State licensees must follow the corresponding state requirements and license conditions.
Apply it
After an HDR fraction, the console indicates source retraction. Before releasing the patient, perform and document the required portable-instrument surveys of the patient and unit. An unexpected radiation indication requires the established source-emergency response rather than reliance on the console message.
Common pitfall: A room monitor, treatment-complete display or patient-only check does not replace the required surveys of both the patient and the afterloader. Temporary afterloading and permanent-implant release have different source-accountability situations.
IAEA Radiation Oncology Physics: A Handbook for Teachers and Students · MDCB Applicant Handbook 2027
Radiation Protection9%
50.How does ALARA guide occupational exposure decisions?
ALARA means keeping exposure as low as reasonably achievable through justified practices and optimized protection. It combines engineering controls, sensible work methods and monitoring rather than simply comparing a badge reading with a limit. Under NRC rules, 10 CFR 20.1101 requires a radiation protection program and use of practicable procedures and engineering controls to achieve occupational and public doses that are ALARA. Exposure limits, investigation levels and local operating procedures serve different purposes. An unusual increase deserves explanation even when it remains below a legal limit.
Apply it
A worker's routine exposure trend rises after a workflow change but remains below the applicable limit. The team investigates time near the source and shielding arrangements, using the trend as an optimization signal rather than dismissing it as compliant.
Common pitfall: Treating a dose limit as a target reverses the purpose of optimization. Reducing prescribed target dose without clinical justification is not an appropriate application of ALARA.
Federal Register :: Request Access · IAEA General Methodologies for Control
51.How do time and distance combine to reduce exposure?
For a steady source, accumulated exposure is proportional to time. Under a point-source approximation without relevant shielding or scatter changes, dose rate follows inverse square with distance. Combined changes multiply: halving time and doubling distance gives one eighth of the original exposure. Real rooms, extended sources and scattering structures may depart from the approximation. Use these relationships to compare controlled scenarios, then rely on appropriate measurements and established protection arrangements for actual working conditions.
Apply it
A task gives a hypothetical exposure of 40 units at one meter over eight minutes. Performing it for four minutes at two meters would give five units under the stated point-source assumptions, combining a half-time factor with a quarter-rate factor.
Common pitfall: Doubling distance does not simply halve point-source dose rate. Applying inverse square indiscriminately near an extended source or in scatter-dominated geometry can misestimate exposure.
IAEA General Methodologies for Control · IAEA Safety Reports Series 47: Radiation Protection in the Design of Radiotherapy Facilities
52.What distinguishes primary and secondary shielding barriers?
A primary barrier is designed for locations that can intercept the useful treatment beam. A secondary barrier protects against sources such as patient scatter and treatment-head leakage where the useful beam is not directed. Shielding design considers beam energy, workload, geometry, occupancy and use of beam directions. A wall's architectural location does not determine its category by itself; the permitted treatment geometry and radiation sources that can reach it establish the required protection.
Apply it
A proposed machine allows the treatment beam to point toward a wall previously exposed only to leakage and scatter. The shielding assessment must reconsider that wall as a possible primary barrier before approving the changed beam-direction capability.
Common pitfall: Calling a wall secondary because it is beside the machine ignores gantry geometry. Shielding cannot be assessed from wall thickness alone without its radiation-use assumptions.
IAEA Safety Reports Series 47: Radiation Protection in the Design of Radiotherapy Facilities
53.How do workload, use factor and occupancy affect shielding?
Workload describes the amount of radiation-producing operation relevant to the shielding calculation. Use factor represents how much of the primary workload is directed toward a particular barrier. Occupancy describes the fraction of relevant time a protected location is occupied. These factors address different parts of the exposure model and must match the actual design assumptions. Changes in clinical workload, beam directions or use of neighboring spaces can invalidate an otherwise unchanged barrier calculation.
Apply it
A storage room beyond a barrier becomes a staffed office. Even without changing the treatment machine, the shielding review must reassess occupancy and the resulting protection requirement because the original assumptions about people beyond the barrier no longer apply.
Common pitfall: Reducing occupancy is not equivalent to reducing machine workload. Applying an unjustified low use factor can underestimate exposure when treatment techniques distribute beam directions differently.
IAEA Safety Reports Series 47: Radiation Protection in the Design of Radiotherapy Facilities
54.Which detector characteristics matter for a radiation survey?
A survey instrument must be suitable for the radiation type, energy, dose-rate range and temporal structure being measured. Ionization chambers, Geiger-Müller instruments and other detectors have different sensitivities, energy responses and saturation behavior. Pulsed treatment beams can challenge some instruments, so an apparently low reading may reflect detector limitations. Confirm calibration, operating checks and measurement geometry. Choose an instrument for the intended protection measurement rather than assuming any radiation detector provides interchangeable results.
Apply it
An instrument gives unexpectedly low readings near a pulsed beam environment. Before concluding that shielding is adequate, the physicist checks whether the detector and measurement mode are validated for that pulse structure and expected dose-rate range.
Common pitfall: A functioning display does not prove a valid measurement. Using a contamination-oriented instrument as a universal dose-rate meter can produce misleading results outside its calibrated response.
IAEA Safety Reports Series 47: Radiation Protection in the Design of Radiotherapy Facilities · IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
55.Which NRC occupational limits and external-monitoring triggers must be distinguished?
For adult occupational exposure under NRC 10 CFR 20.1201, annual limits include TEDE of 50 mSv; the sum of deep-dose equivalent and committed dose equivalent to any individual organ or tissue other than the lens of 500 mSv; lens dose equivalent of 150 mSv; and shallow-dose equivalent to skin or any extremity of 500 mSv. Under 20.1208, occupational embryo/fetus dose for a declared pregnant worker is limited to 5 mSv over pregnancy, with efforts to avoid substantial variation above a uniform monthly exposure rate. Declaration is voluntary and written. If the embryo/fetus dose already exceeds 5 mSv, or is within 0.5 mSv of it at declaration, the limit is deemed satisfied when additional dose during the remainder does not exceed 0.5 mSv.
Apply it
Under 10 CFR 20.1502, adult external monitoring is required when annual external dose is likely to exceed 10% of an applicable limit; 5 mSv is therefore the TEDE-related screening level, not the adult annual limit. External monitoring of a declared pregnant worker is required when deep-dose equivalent is likely to exceed 1 mSv over the entire pregnancy. A projected 1.2 mSv meets that monitoring trigger despite being below the 5 mSv embryo/fetus limit. Interpret badges using correct wearer assignment, placement and work history.
Common pitfall: Monitoring thresholds and dose limits have different functions. The pregnancy monitoring trigger concerns deep-dose equivalent, while the embryo/fetus limit includes maternal external exposure and radionuclides in the mother and embryo/fetus. These NRC criteria must be distinguished from corresponding Agreement State requirements and from rules governing machine-produced radiation.
Federal Register :: Request Access · Federal Register :: Request Access · Federal Register :: Request Access
Quality Assurance & Standard of Care9%
56.How do commissioning and routine QA serve different purposes?
Commissioning establishes that a system's modeled and measured performance is suitable for its intended clinical uses. Routine QA checks whether relevant performance remains consistent with established expectations. Treatment planning commissioning should include representative field sizes, modifiers, heterogeneities and clinical configurations, with attention to model limitations. An end-to-end test evaluates the connected workflow. Passing a narrow routine check does not establish that a newly introduced technique or configuration was adequately commissioned.
Apply it
A department adds a small-field technique that lies outside its prior validation range. Existing monthly output results remain stable, but the team performs appropriate calculation and workflow validation before using the new configuration clinically.
Common pitfall: Routine constancy cannot prove validity outside the commissioned range. Conversely, comprehensive initial commissioning does not eliminate the need to detect later changes or software-related effects.
57.What makes a plan and chart check clinically meaningful?
A meaningful review connects patient identity, clinical intent, prescription, contours, calculation settings, dose distribution and delivery parameters. It tests whether the plan is appropriate and internally consistent, rather than merely complete. Independent review should examine high-consequence failure points and discrepancies, including dose per fraction, total fractions, laterality, accessories and prior treatment. The dosimetrist identifies and resolves issues within professional responsibilities, while prescription and medical acceptance remain with the responsible treating clinician.
Apply it
A plan's total dose matches the prescription, but its fraction count differs, changing dose per fraction. The reviewer pauses approval and reconciles the discrepancy, recognizing that agreement in total dose alone cannot establish an equivalent treatment.
Common pitfall: A completed checklist can still miss a clinically meaningful mismatch if items are reviewed in isolation. Resolving a discrepancy does not authorize independently changing the prescription.
AAPM TG-275: Strategies for Effective Physics Plan and Chart Review in Radiation Therapy · MDCB Applicant Handbook 2027
58.How should patient-specific delivery QA be interpreted?
Patient-specific measurements test aspects of agreement between planned and delivered radiation under the measurement conditions. Detector resolution, calibration, setup, analysis criteria and sensitivity determine which errors can be detected. A gamma pass rate summarizes a chosen dose-distance comparison but does not identify every clinical failure or establish prescription correctness. Investigate discrepancies in their spatial and dosimetric context, and combine measurement results with independent plan review and machine-deliverability checks.
Apply it
An IMRT measurement passes its comparison criteria, but chart review finds the wrong approved fractionation attached to the plan. The measurement remains evidence about delivery agreement, while the treatment-intent mismatch requires separate correction before use.
Common pitfall: Treating a high pass rate as comprehensive approval overlooks common-input and clinical-intent errors. A low pass rate also requires investigation rather than automatic attribution to machine failure.
AAPM TG-275: Strategies for Effective Physics Plan and Chart Review in Radiation Therapy · AAPM Medical Physics Practice Guideline 5.b: Commissioning and QA of Treatment Planning Dose Calculations
59.Why must record-and-verify data match the approved plan version?
Record-and-verify systems compare delivery parameters with stored treatment instructions and document treatment. Their protection depends on correct source data and a controlled approval workflow. If the wrong plan version is imported and approved, the system may faithfully enforce an incorrect treatment. Verify plan identity, fractionation, machine, beam parameters, accessories and relevant imaging instructions after transfer or revision. Traceable version control helps distinguish intended changes from obsolete or inadvertently selected treatment data.
Apply it
A revised plan is approved, but the treatment system still displays the earlier beam set. The team reconciles the receiving system with the approved revision and verifies required parameters before delivery rather than relying on the absence of an interlock.
Common pitfall: An interlock-free setup proves agreement with stored instructions, not with clinical intent. A successful transfer message also cannot establish that the correct revision was selected.
AAPM TG-275: Strategies for Effective Physics Plan and Chart Review in Radiation Therapy
60.How should a near miss lead to safer practice?
A near miss is valuable because it exposes a failure pathway before patient harm occurs. Reporting should capture what happened, how it was detected and which conditions allowed it, while following local escalation procedures. Analysis looks beyond individual actions to workflow design, interfaces and defenses. Corrective actions should address the identified mechanism and be assessed for effectiveness. Shared incident learning, including RO-ILS, helps other teams recognize similar vulnerabilities without requiring them to experience the same event.
Apply it
A mislabeled structure is caught before plan approval. The team reports the near miss, examines why naming and selection checks failed, and adds a targeted input-validation step whose effectiveness can be reviewed in subsequent cases.
Common pitfall: Closing the event after reminding one person to be careful leaves the underlying pathway intact. Near misses deserve learning even when existing defenses prevented delivery.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Use the full official seven-domain outline to identify gaps; this guide selects 60 concepts rather than exhausting every listed task.
- Give Treatment Planning the largest share of study time: connect anatomical targets, fractionation, protocol metrics, optimization tradeoffs and spatial dose review.
- Practise units and assumptions before arithmetic in decay, inverse-square, MU, BED, EQD2 and brachytherapy time calculations.
- Distinguish nominal plan quality from reliability under setup, motion, range, registration and anatomical uncertainty.
- Review anatomy and contours in three planes, then connect each DVH metric to its actual anatomical location.
- Prepare separately for the issuer's plan-navigation and contouring tasks using the approved candidate resources.
- Learn what each safety check can detect: commissioning, independent calculation, measurement, chart review and transfer verification address different failure pathways.
A practical preparation plan
1. Map the complete outline
Read the January 2027 handbook's matrix and mark each task as confident, developing or unfamiliar. Allocate study broadly according to the published weights, with Treatment Planning receiving the greatest attention.
2. Build calculation fluency
Work short problems in decay, distance scaling, MU, biological dose and source-time scaling. Write the physical quantity, units, reference conditions and assumptions before substituting values.
3. Pair anatomy with dose
For each practice plan, identify targets and organs in all three planes. Explain coverage, hotspots, gradients and protocol metrics together, including where a favorable summary statistic could conceal a local problem.
4. Challenge the nominal plan
Introduce plausible setup, motion, density, range or anatomical changes. Decide which require a correction, sensitivity calculation, new imaging, adaptive assessment or clarification of clinical intent.
5. Rehearse practical assessment skills
Use the issuer's available candidate tutorials to practise contour visibility, image navigation, windowing, dose levels, DVH views and required contouring actions. Follow the handbook's access schedule and platform instructions.
6. Review errors by mechanism
Complete the original questions, then explain why every alternative is less suitable. Revisit weak concepts with active-recall cards and a new case; use results to guide study rather than infer a certification outcome.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- MDCB Applicant Handbook
- MDCB Applicant Handbook 2027
- MDCB CMD Test Specifications Matrix—2023 Job Task Analysis
- MDCB Announce Dates for the 2027 Exam
- MDCB Exam Development
- MDCB News
- IAEA Radiation Oncology Physics: A Handbook for Teachers and Students
- IAEA-TECDOC-1560: Dose Reporting in Ion Beam Therapy
- AAPM Report 166: The Use and QA of Biologically Related Models for Treatment Planning
- 21 Years of Biologically Effective Dose
- AAPM TG-203: Management of Radiotherapy Patients with Implanted Cardiac Pacemakers and Defibrillators
- AAPM Report 202: Physical Uncertainties in the Planning and Delivery of Light Ion Beam Treatments
- AAPM Report 85: Tissue Inhomogeneity Corrections for Megavoltage Photon Beams
- AAPM TG-132: Use of Image Registration and Fusion Algorithms and Techniques in Radiotherapy
- AAPM TG-324 Report 91.b: The Management of Respiratory Motion in Radiation Oncology
- AAPM TG-71: Monitor Unit Calculations for External Photon and Electron Beams
- AAPM TG-275: Strategies for Effective Physics Plan and Chart Review in Radiation Therapy
- AAPM Medical Physics Practice Guideline 5.b: Commissioning and QA of Treatment Planning Dose Calculations
- ASTRO Radiation Oncology Incident Learning System
- IAEA Safety Reports Series 47: Radiation Protection in the Design of Radiotherapy Facilities
- IAEA General Methodologies for Control
- AAPM Report 202: Physical Uncertainties in the Planning and Delivery of Light Ion Beam Treatments—Full Report
- RPT_91.pdf
- 1208.2707
- Federal Register :: Request Access
- Federal Register :: Request Access
- Federal Register :: Request Access
- Federal Register :: Request Access
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.